lsm880 inverted confocal microscope (Carl Zeiss)
Structured Review
Lsm880 Inverted Confocal Microscope, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 99/100, based on 2152 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lsm880/Primovert+Compact+Inverted+Microscope/pmc12926278-48-13-12
Average 99 stars, based on 2152 article reviews
Images
Related Articles
Confocal:Article Title: Enhanced the Trans‐Cleavage Activity of CRISPR‐Cas12a Using Metal‐Organic Frameworks as Stimulants for Efficient Electrochemical Sensing of Circulating Tumor DNA Article Snippet: Meanwhile, their X‐ray diffraction (XRD) data were collected by a D8 Advance diffractometer (Bruker, Germany). .. Additionally, the images of confocal laser scanning microscopy for Cas12a/FAM‐crRNA@Mn‐MOFs were recorded using Laser-Scanning Microscopy:Article Title: Enhanced the Trans‐Cleavage Activity of CRISPR‐Cas12a Using Metal‐Organic Frameworks as Stimulants for Efficient Electrochemical Sensing of Circulating Tumor DNA Article Snippet: Meanwhile, their X‐ray diffraction (XRD) data were collected by a D8 Advance diffractometer (Bruker, Germany). .. Additionally, the images of confocal laser scanning microscopy for Cas12a/FAM‐crRNA@Mn‐MOFs were recorded using Fluorescence:Article Title: Leveraging T cell-specific fusogenicity of HIV for in vivo mRNA delivery to produce human CAR-T cells Article Snippet: Article Imaging:Article Title: Intersectin and endophilin condensates prime synaptic vesicles for release site replenishment. Article Snippet: .. Live-cell Airyscan imaging and data analysis For Airyscan imaging, samples were imaged in Modification:Article Title: PD-L1 Antibody-Modified Plant-Derived Nanovesicles Carrying a STING Agonist for the Combinational Immunotherapy of Melanoma Article Snippet: Combination therapies for melanoma face challenges due to asynchronous drug delivery and associated toxicity, underscoring the need for advanced delivery systems.. While immune checkpoint inhibitors (ICIs) enhance T cell activity, optimal cytotoxic responses require efficient antigen presentation by mature dendritic cells (DCs), which are often functionally impaired in the tumor microenvironment.. Thus, effective treatment requires coordinated T cell activation, DC-mediated priming, and direct tumor suppression. Labeling:Article Title: PD-L1 Antibody-Modified Plant-Derived Nanovesicles Carrying a STING Agonist for the Combinational Immunotherapy of Melanoma Article Snippet: Combination therapies for melanoma face challenges due to asynchronous drug delivery and associated toxicity, underscoring the need for advanced delivery systems.. While immune checkpoint inhibitors (ICIs) enhance T cell activity, optimal cytotoxic responses require efficient antigen presentation by mature dendritic cells (DCs), which are often functionally impaired in the tumor microenvironment.. Thus, effective treatment requires coordinated T cell activation, DC-mediated priming, and direct tumor suppression. Whole Genome Amplification:Article Title: PD-L1 Antibody-Modified Plant-Derived Nanovesicles Carrying a STING Agonist for the Combinational Immunotherapy of Melanoma Article Snippet: Combination therapies for melanoma face challenges due to asynchronous drug delivery and associated toxicity, underscoring the need for advanced delivery systems.. While immune checkpoint inhibitors (ICIs) enhance T cell activity, optimal cytotoxic responses require efficient antigen presentation by mature dendritic cells (DCs), which are often functionally impaired in the tumor microenvironment.. Thus, effective treatment requires coordinated T cell activation, DC-mediated priming, and direct tumor suppression. Confocal Microscopy:Article Title: PD-L1 Antibody-Modified Plant-Derived Nanovesicles Carrying a STING Agonist for the Combinational Immunotherapy of Melanoma Article Snippet: Combination therapies for melanoma face challenges due to asynchronous drug delivery and associated toxicity, underscoring the need for advanced delivery systems.. While immune checkpoint inhibitors (ICIs) enhance T cell activity, optimal cytotoxic responses require efficient antigen presentation by mature dendritic cells (DCs), which are often functionally impaired in the tumor microenvironment.. Thus, effective treatment requires coordinated T cell activation, DC-mediated priming, and direct tumor suppression. |

